Pegylated Recombinant HumanErythropoietin Injection 50 ug-0.3 ml

Pegylated Recombinant HumanErythropoietin Injection 50 ug-0.3 ml Specification

Salt Composition
50 ug / 0.3 ml

Origin
India

Dosage Form
Liquid

Storage Instructions
Dry Place

Shelf Life
Up to 24 Months

Pegylated Recombinant HumanErythropoietin Injection 50 ug-0.3 ml Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Packs Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Pegylated Recombinant HumanErythropoietin Injection 50 ug-0.3 ml

Pegylated Recombinant Human Erythropoietin Injection 50 ug-0.3 ml is a liquid medication used to treat anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy. The medication contains 50 ug of erythropoietin per 0.3 ml of injection and is manufactured in India. The medication is administered through injection and is recommended to be stored in a dry place. The shelf life of the medication is up to 24 months. The medication works by stimulating the production of red blood cells in the body, which can improve symptoms of anemia and increase energy levels.

FAQs of Pegylated Recombinant HumanErythropoietin Injection 50 ug-0.3 ml:

Q: What is Pegylated Recombinant Human Erythropoietin Injection used for?

A: Pegylated Recombinant Human Erythropoietin Injection is used to treat anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy.

Q: How is Pegylated Recombinant Human Erythropoietin Injection administered?

A: Pegylated Recombinant Human Erythropoietin Injection is administered through injection.

Q: What is the recommended dosage for Pegylated Recombinant Human Erythropoietin Injection?

A: The recommended dosage of Pegylated Recombinant Human Erythropoietin Injection depends on the individuals condition and should be determined by a healthcare professional.